Cargando…
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
BACKGROUND: Prospective, population-based study of an 8-year follow up. To determine the direct cost of diabetic retinopathy [DR], evaluating our screening programme and the cost of treating DR, focusing on diabetic macular oedema [DMO] after anti-vascular endothelial growth factor [anti-VEGF] treat...
Autores principales: | Romero-Aroca, Pedro, de la Riva-Fernandez, Sofia, Valls-Mateu, Aida, Sagarra-Alamo, Ramon, Moreno-Ribas, Antonio, Soler, Nuria, Puig, Domenec |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973531/ https://www.ncbi.nlm.nih.gov/pubmed/27491545 http://dx.doi.org/10.1186/s12886-016-0318-x |
Ejemplares similares
-
Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population
por: Romero-Aroca, Pedro, et al.
Publicado: (2016) -
Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study
por: Romero-Aroca, Pedro, et al.
Publicado: (2017) -
A Clinical Decision Support System for Diabetic Retinopathy Screening: Creating a Clinical Support Application
por: Romero-Aroca, Pedro, et al.
Publicado: (2019) -
Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study
por: Romero-Aroca, Pedro, et al.
Publicado: (2018) -
Real-world outcomes of a clinical decision support system for diabetic retinopathy in Spain
por: Romero-Aroca, Pedro, et al.
Publicado: (2022)